Corticotropin releasing factor antagonists
   
   

Corticotropin-releasing factor (CRF) antagonists having the formulae ##STR1## wherein the dashed lines, A, B, Y, Z, G, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.16 and R.sub.17 are as defined in the application, and processes for preparing them. These compounds and their pharmaceutically acceptable salts are useful in the treatment disorders including CNS and stress-related disorders.

 
Web www.patentalert.com

< Prostate boundary segmentation from 2D and 3D ultrasound images

< Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-a cetamide and method of production

> Substituted quinolin-2-one derivatives useful as antiproliferative agents

> Heterocyclic compounds useful as inhibitors of tyrosine kinases
~ 00156